Immunomodulatory Properties of Ketamine in Sepsis
Clinical trial NCT01089361 · COMPLETED
Trial details
- NCT number
- NCT01089361
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2010-06-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.